ストックスクリーナーアプリを入手
2.67
1.14%
0.03
アフターアワーズ：
2.67
前日終値:
$2.64
開ける：
$2.6396
24時間の取引高:
14,306
Relative Volume:
0.19
時価総額：
$6.24M
収益：
$102.80K
当期純損益:
$-5.32M
株価収益率:
-0.7026
EPS:
-3.8
ネットキャッシュフロー:
$-5.45M
1週間 パフォーマンス:
-1.84%
1か月 パフォーマンス:
+21.92%
6か月 パフォーマンス:
+15.58%
1年 パフォーマンス:
-27.64%
1日の値動き範囲:
$2.6004
$2.70
1週間の範囲:
$2.5922
$2.8599
52週間の値動き範囲:
$1.69
$6.90
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
名前
Creative Medical Technology Holdings Inc
セクター
電話
480-399-2822
住所
211 E. OSBORN RD., PHOENIX
CELZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.67 | 6.24M | 102.80K | -5.32M | -5.45M | -3.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Creative Medical Technology Holdings Inc (CELZ) 最新ニュース
Mergers & Acquisitions Tracker - Plastics News
Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Roth Capital Has Negative Forecast for CELZ Q2 Earnings - Defense World
Creative Medical (CELZ) Price Target Reduced by Roth Capital | C - GuruFocus
Creative Medical (CELZ) Price Target Reduced by Roth Capital | CELZ Stock News - GuruFocus
Should You Be Impressed By Creative Global Technology Holdings Limited's (NASDAQ:CGTL) ROE? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Flora Growth (FLGC), Cardinal Health (CAH) and Zevra Therapeutics (ZVRA) - The Globe and Mail
Creative Medical Technology Holdings: Initiating Coverage With A Sell Rating - Seeking Alpha
$12+ Bn Chronic Lower Back Pain Market Opportunities and - GlobeNewswire
Creative Medical Technology Holdings Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Creative Medical Technology Holdings Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain - Barchart.com
Degenerative Disc Disease Treatment Market Size in 7MM - openPR.com
Creative Medical Technology (CELZ) Projected to Post Earnings on Friday - Defense World
Exosome Cell and Gene Therapy Market Deep Research with Forecast - openPR.com
Companies Like Creative Medical Technology Holdings (NASDAQ:CELZ) Are In A Position To Invest In Growth - Yahoo
Creative Science, a CIMA Animal Health Company, Acquires Astaria Global - Yahoo Finance
Creative Foam buys medical supplier AccuMed from Lear - Plastics News
Venus Shines Again, ENZ To Be Delisted, SLP, CERT On Watch - RTTNews
Head-To-Head Contrast: Atara Biotherapeutics (NASDAQ:ATRA) and Creative Medical Technology (NASDAQ:CELZ) - Defense World
Exosomes Drug Market Projected To Witness Substantial Growth, - openPR.com
Longevity Health to combine with 20/20 BioLabs in all-stock deal (XAGE:NASDAQ) - Seeking Alpha
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Exosomes Market Detailed In New Research Report 2025 | Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC - newstrail.com
CELZ stock touches 52-week low at $1.9 amid market challenges - Investing.com Canada
CELZ stock touches 52-week low at $1.9 amid market challenges By Investing.com - Investing.com South Africa
Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders - MSN
Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews
Reviewing MiNK Therapeutics (NASDAQ:INKT) & Creative Medical Technology (NASDAQ:CELZ) - The AM Reporter
Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World
CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Creative Medical Technology (CELZ) to Release Quarterly Earnings on Friday - The AM Reporter
Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World
Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World
Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq
FDA approves expanded trial for back pain cell therapy - Investing.com India
Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial -March 20, 2025 at 08:27 am EDT - MarketScreener
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times
Nanoparticle Drug Delivery Market Growth, Generated - openPR.com
Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD
Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD
Creative Medical Technology Holdings Inc (CELZ) 財務データ
収益
当期純利益
現金流量
EPS
Creative Medical Technology Holdings Inc (CELZ) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Finger Michael H. | Director |
Feb 18 '25 |
Sale |
5.00 |
750 |
3,750 |
1,101 |
1.45%
0.86%
大文字化:
|
ボリューム (24 時間):